International Patient Summary Implementation Guide
1.0.0 - STU 1

This page is part of the International Patient Summary Implementation Guide (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions

Medications (example) - IPS

Summary

Defining URL:http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips
Version:1.0.0
Name:MedicationCodesUvIps
Status:Active
Title:Medications (example) - IPS
Definition:

This value set provides an example of possible coded concepts representing:

  • medicinal products
  • packaged medicinal products
  • medications based on their generic composition of:
    • active substance(s) (e.g. IDMP PhPID Active Substance Stratum Level 1)
    • active substance(s) with strength (e.g. IDMP PhPID Active Substance Stratum Level 2)
    • active substance(s) with administrable dose form (e.g. IDMP PhPID Active Substance Stratum Level 3)
    • active substance(s) with strength and administrable dose form (e.g. IDMP PhPID Active Substance Stratum Level 4)

Please note that this Value set is not representing any IDMP identifier. It is envisioned that a future version will be based on the IDMP IDs when available for actual use.

Publisher:Health Level Seven International - Patient Care Work Group
Copyright:

Copyright statements for terminologies included in this artifact:

  • This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyrighted material of the International Health Terminology Standards Development Organisation (IHTSDO). Where an implementation of this artefact makes use of SNOMED CT content, the implementer must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org
  • National Drug Code (NDC). NDC is copyright Food and Drug Administration. Terms & Conditions in https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory.
  • RxNorm. RxNorm is copyright Unified Medical Language System® (UMLS®). Terms & Conditions in https://uts.nlm.nih.gov/license.html https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html.
  • Autorizzazione all'Immissione in Commercio (AIC). AIC is owned by the Italian Medicines Agency (AIFA). Terms & Conditions in https://www.aifa.gov.it/copyright.
  • Code Identifiant de Spécialité (CIS). CIS is owned by the French Ministry of Solidarity and Health. Terms & Conditions in https://solidarites-sante.gouv.fr/soins-et-maladies/medicaments/glossaire/article/code-cis
Source Resource:XML / JSON / Turtle

References

Logical Definition (CLD)

This value set includes codes based on the following rules:

  • Include these codes as defined in http://snomed.info/sct
    CodeDisplay
    777067000Acetaminophen only product
    774587000Amoxicillin and clavulanic acid only product
    776556004Lithium citrate only product
    774409003Acenocoumarol only product
    780130002Acetaminophen only product in rectal dose form
    778315007Amoxicillin and clavulanic acid only product in oral dose form
    779725005Lithium citrate only product in oral dose form
    778207007Acenocoumarol only product in oral dose form
    322257001Paracetamol 250 mg rectal suppository
    392259005Amoxicillin 875 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet
    766489003Lithium citrate 104 mg/mL oral solution
    319740004Acenocoumarol 1 mg oral tablet
  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm
    CodeDisplay
    331055Amoxicillin 1000 MG
    437158Acetaminophen 100 MG
    332122lithium citrate 60 MG/ML
  • Include these codes as defined in http://hl7.org/fhir/sid/ndc
    CodeDisplay
    50436-3129Amoxicillin and Clavulanate Potassium 875 mg/1 125 mg/1 TABLET, FILM COATED
  • Include these codes as defined in http://hl7.org/fhir/sid/ndc
    CodeDisplay
    50436-3129-1Amoxicillin and Clavulanate Potassium 875 mg/1 125 mg/1 20 TABLET, FILM COATED in 1 BOTTLE (50436-3129-1)

 

Expansion

This value set contains 17 concepts

Expansion based on:

  • RxNorm version ??
  • SNOMED CT International edition 09-Mar 2020
CodeSystemDisplayDefinition
777067000http://snomed.info/sctAcetaminophen only product
774587000http://snomed.info/sctAmoxicillin and clavulanic acid only product
776556004http://snomed.info/sctLithium citrate only product
774409003http://snomed.info/sctAcenocoumarol only product
780130002http://snomed.info/sctAcetaminophen only product in rectal dose form
778315007http://snomed.info/sctAmoxicillin and clavulanic acid only product in oral dose form
779725005http://snomed.info/sctLithium citrate only product in oral dose form
778207007http://snomed.info/sctAcenocoumarol only product in oral dose form
322257001http://snomed.info/sctParacetamol 250 mg rectal suppository
392259005http://snomed.info/sctAmoxicillin 875 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet
766489003http://snomed.info/sctLithium citrate 104 mg/mL oral solution
319740004http://snomed.info/sctAcenocoumarol 1 mg oral tablet
331055http://www.nlm.nih.gov/research/umls/rxnormAmoxicillin 1000 MG
437158http://www.nlm.nih.gov/research/umls/rxnormAcetaminophen 100 MG
332122http://www.nlm.nih.gov/research/umls/rxnormlithium citrate 60 MG/ML
50436-3129http://hl7.org/fhir/sid/ndcAmoxicillin and Clavulanate Potassium 875 mg/1 125 mg/1 TABLET, FILM COATED
50436-3129-1http://hl7.org/fhir/sid/ndcAmoxicillin and Clavulanate Potassium 875 mg/1 125 mg/1 20 TABLET, FILM COATED in 1 BOTTLE (50436-3129-1)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code